Hani, U.; Paramshetti, S.; Angolkar, M.; Alqathanin, W.K.; Alghaseb, R.S.; Al Asmari, S.M.; Alsaab, A.A.; Fatima, F.; Osmani, R.A.M.; Gundawar, R.
Cyclodextrin-Nanosponge-Loaded Cyclo-Oxygenase-2 Inhibitor-Based Topical Gel for Treatment of Psoriatic Arthritis: Formulation Design, Development, and In vitro Evaluations. Pharmaceuticals 2024, 17, 1598.
https://doi.org/10.3390/ph17121598
AMA Style
Hani U, Paramshetti S, Angolkar M, Alqathanin WK, Alghaseb RS, Al Asmari SM, Alsaab AA, Fatima F, Osmani RAM, Gundawar R.
Cyclodextrin-Nanosponge-Loaded Cyclo-Oxygenase-2 Inhibitor-Based Topical Gel for Treatment of Psoriatic Arthritis: Formulation Design, Development, and In vitro Evaluations. Pharmaceuticals. 2024; 17(12):1598.
https://doi.org/10.3390/ph17121598
Chicago/Turabian Style
Hani, Umme, Sharanya Paramshetti, Mohit Angolkar, Wajan Khalid Alqathanin, Reema Saeed Alghaseb, Saja Mohammed Al Asmari, Alhanouf A. Alsaab, Farhat Fatima, Riyaz Ali M. Osmani, and Ravi Gundawar.
2024. "Cyclodextrin-Nanosponge-Loaded Cyclo-Oxygenase-2 Inhibitor-Based Topical Gel for Treatment of Psoriatic Arthritis: Formulation Design, Development, and In vitro Evaluations" Pharmaceuticals 17, no. 12: 1598.
https://doi.org/10.3390/ph17121598
APA Style
Hani, U., Paramshetti, S., Angolkar, M., Alqathanin, W. K., Alghaseb, R. S., Al Asmari, S. M., Alsaab, A. A., Fatima, F., Osmani, R. A. M., & Gundawar, R.
(2024). Cyclodextrin-Nanosponge-Loaded Cyclo-Oxygenase-2 Inhibitor-Based Topical Gel for Treatment of Psoriatic Arthritis: Formulation Design, Development, and In vitro Evaluations. Pharmaceuticals, 17(12), 1598.
https://doi.org/10.3390/ph17121598
